Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
Gardin, Anne, Ufer, Mike, Legangneux, Eric, Rossato, Gianluca, Jin, Yi, Su, Zhenzhong, Pal, Parasar, Li, Wenkui, Shakeri-Nejad, Kasra
Published in Clinical pharmacokinetics (01.03.2019)
Published in Clinical pharmacokinetics (01.03.2019)
Get full text
Journal Article
Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes
Gardin, Anne, Shakeri-Nejad, Kasra, Feller, Andrea, Huth, Felix, Neelakantham, Srikanth, Dumitras, Swati
Published in European journal of clinical pharmacology (01.11.2019)
Published in European journal of clinical pharmacology (01.11.2019)
Get full text
Journal Article
Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design)
Hung, Noelyn Anne, Costa, Fernando Guillermo, Hung, Cheung‐Tak, Rosenberg, Mónica Esther
Published in Clinical pharmacology in drug development (01.07.2020)
Published in Clinical pharmacology in drug development (01.07.2020)
Get full text
Journal Article
Cardiodynamic Interactions between Two S1P 1 Receptor Modulators in an Experimental Clinical Setting: Different Pharmacokinetic Properties as an Opportunity to Mitigate First-Dose Heart Rate Effects
Juif, Pierre-Eric, Ufer, Mike, Dingemanse, Jasper
Published in International journal of molecular sciences (01.07.2019)
Published in International journal of molecular sciences (01.07.2019)
Get full text
Journal Article